A. Destée

Inserm — France

Medicine · Health Sciences

67h-index19.7kcitations499works22.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(183), Neurological disorders and treatments(145), Genetic Neurodegenerative Diseases(69), Botulinum Toxin and Related Neurological Disorders(43), Neurological diseases and metabolism(34)

Publications493 total

A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
npj Parkinson s Disease·2024· 22 citedOpen Access
A potential patient stratification biomarker for Parkinso’s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
2023· 2 citedOpen Access
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers
npj Parkinson s Disease·2023· 21 citedOpen Access
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers
2022Open Access
Correction to: Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
Journal of Neural Transmission·2020· 1 citedOpen Access
Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
Journal of Neural Transmission·2020· 7 citedOpen Access
Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study
Drugs & Aging·2020· 14 cited
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients
Biochemical Journal·2019· 36 citedOpen Access
LRP10 in α-synucleinopathies
The Lancet Neurology·2018· 16 citedOpen Access
Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
Frontiers in Molecular Neuroscience·2018· 47 citedOpen Access
NADPH oxidases in Parkinson’s disease: a systematic review
Molecular Neurodegeneration·2017· 147 citedOpen Access
Writing tremor: Should we look for a TOR1A mutation?
Journal of the Neurological Sciences·2017· 1 citedOpen Access
L‐<scp>DOPA</scp>‐induced dyskinesias, motor fluctuations and health‐related quality of life: the <scp>COPARK</scp> survey
European Journal of Neurology·2017· 52 citedOpen Access
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Neurology·2017· 82 citedOpen Access
Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways
Neuroscience & Biobehavioral Reviews·2016· 37 cited
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease
Neurobiology of Disease·2016· 15 citedOpen Access
Clinical Characteristics of Voice, Speech, and Swallowing Disorders in Oromandibular Dystonia
Journal of Speech Language and Hearing Research·2016· 18 cited
Novel heterozygous mutation in <i>ANO3</i> responsible for craniocervical dystonia
Movement Disorders·2016· 22 citedOpen Access
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
The American Journal of Human Genetics·2016· 429 citedOpen Access
A schematic representation of the three-stimulus visual oddball paradigm (with the circle task on the left and the square task on the right).
Figshare·2015Open Access
page 1 of 25Next →

Frequent Co-authors

Luc Defebvre(18), Marie Vidailhet(16), David Devos(15), Kathy Dujardin(15), Pierre Krystkowiak(14), Jean‐Christophe Corvol(11), François Tison(11), Alexis Brice(11), Yves Agid(10), Pierre Pollak(10), Caroline Moreau(9), Suzanne Lesage(9), Alexandra Dürr(9), Olivier Rascol(9), S. Blond(8), Ebba Lohmann(8), Philippe Damier(8), Régis Bordet(7), François Viallet(7), Christine Tranchant(6)